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A subset of patients with chronic plaque psoriasis exhibits severely photosensitive psoriasis (PP) with a
pronounced seasonal pattern, but the pathomechanism is not understood. We performed two related studies;
first, a detailed clinical characterization of PP, and second, a controlled investigation exploring the underlying
pathomechanisms through the assessment of disease onset after photoprovocation. Patients with PP (n¼ 20)
showed striking female predominance (19F:1M), very low mean age of psoriasis onset (11 years, range 2–24),
family history of psoriasis (13/20), a strong HLA–Cw*0602 association (16/17), and a rapid abnormal clinical
response to broadband UVA, comprising erythema±scaling plaques (17/20). Subsequently, patients with PP
(n¼ 10), non-PP (n¼ 9), and healthy volunteers (n¼ 11) were challenged with low-dose broadband UVA on 3
consecutive days, and serial biopsies were taken after 6 hours to 7 days and from unchallenged skin.
Histological changes consistent with early psoriasis occurred in 4 of 10 PP patients, but in neither of the control
groups, with significant dermal infiltration by neutrophils, CD4þ , CD8þ , and CD45ROþ cells at 24 h,
accompanied by acanthosis. Thus, a phenotypically distinct subset of psoriasis has been characterized. In
contrast with earlier assumptions, UV can provoke psoriasiform features rapidly de novo; a role for memory
effector T cells is supported in the early phase.
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INTRODUCTION
Exposure to UVR is usually beneficial in psoriasis, but it is
recognized that in a significant minority, estimated between 5
and 20% of patients, psoriasis worsens (Lane and Crawford,
1937; Lomholt, 1963; Farber et al., 1968; Ros and Eklund,
1987). The mechanisms underlying this are poorly under-
stood, but are proposed to include Ko¨bnerization after
sunburn in fair skin (Bielicky and Kvicalova, 1964; Frain-
Bell, 1979) or after polymorphic light eruption (Ros and
Eklund, 1987; Ros and Wennersten, 1986), coexistence of
other photosensitivity disorders (Millns and Muller, 1980;
Doyle, 1984), and direct UVR triggering or exacerbation of
psoriasis de novo. It is assumed that de novo photoprovoked
psoriasis takes several days to manifest after UVR, and that a
rapid onset of a photosensitive reaction in patients with
psoriasis is more likely to denote a coexistent photosensitivity
disorder (Ros and Wennersten, 1986).
In our tertiary referral psoriasis clinic, we have identified a
subset of patients with severely photosensitive psoriasis (PP), in
whom the condition is predominantly photodistributed and is
severe in the summer months, whereas it is mild or absent in
winter. Moreover, they show a relative ease of provocation by
artificial UV sources. This has presented an opportunity both for
a detailed characterization of their phenotype and for an
examination of the underlying pathomechanisms. First, we
performed a detailed clinical characterization of 20 patients
identified to have PP. Second, we conducted a controlled study
of the histological and molecular responses of PP to low-dose
UV provocation, with the challenge selected to avoid risk of
Ko¨bnerization as a confounder. Further, we included two control
groups to evaluate for any potential influence of the Ko¨bneriza-
tion phenomenon or of a nonspecific UV effect. Thus, 10
patients with PP, 9 with chronic plaque psoriasis and no history
of UV exacerbation (P), and 11 volunteers with healthy skin (N)
were recruited. Sequential skin biopsies were taken after
exposure to low-dose broadband (bb)UVA, and evaluated
histologically and immunohistochemically. The principal aims
of our studies were to clinically characterize this subset
of patients with severely PP, to evaluate impressions from
our clinical practice that PP could be rapidly and directly
provoked by UV, and to explore the role of potential
pathogenic T-cell subsets that we hypothesize are key to the
early evolution of PP.
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Severely PP shows pronounced female preponderance,
develops at an early age, and is associated with a positive
family history in the majority. Among the 20 patients with
PP, there was a striking female bias, with 19 females to one
male (Table 1). Two-thirds, that is, 13 of 20 patients, had a
positive family history of psoriasis, 7 in first-degree relatives.
There was a marked early age of onset for many patients, with
12 of 20 developing psoriasis under 10 years of age. Eleven
patients had PP from the outset, whereas others noticed a
worsening of their condition after UV exposure later in life;
three had even found UV helpful initially. Their psoriasis
occurred predominantly on exposed sites (Figure 1) in
summer months, with an absent or minimal involvement in
winter. Eight required systemic medication for psoriasis,
solely or predominantly in the summer. Five of 20 were of
skin phototype I.
Severely PP is associated with HLA–Cw*0602. Of the 17
patients undergoing HLA typing, 2 were homozygous positive
for HLA–Cw*0602 and 14 were heterozygous, indicating a
strong association with this allele. No specific pattern of the
HLA–DRB1* distribution was noted, and no patient carried
the HLA–DRB1*0407 allele associated with photosensitivity,
namely, actinic prurigo.
Monochromated light testing shows normal minimal erythe-
ma doses to narrowband UVB, UVA, and visible radiation,
whereas broadband UVA provocation elicits a rapid
abnormal clinical response in the majority of patients with
severely PP. Monochromator light testing revealed normal
responses to narrow bandwidths of UVB, UVA, and visible
light in all but one patient tested; the latter had a slightly
lowered erythemal threshold of 14 J cm2 to UVA at 370 nm.
Broadband UVA provocation testing was abnormal in 17 of
the 20 patients, comprising macular erythema, sometimes
accompanied by small scaly plaques consistent with psoriasis
(Figure 2). Two of the three patients with negative provoca-
tion were taking systemic medication during photoinvestiga-
tion (1 hydroxycarbamide, 1 fumarate), which may explain
their negative results. Nine patients were exquisitely sensitive
to bbUVA on testing and developed visible cutaneous
features after only one exposure to bbUVA at 20 J cm2.
Three patients developed a papular erythema clinically
consistent with polymorphic light eruption. Serum investiga-
tions showed a weakly positive antinuclear antibody in four
patients (titer 1 in 100), moderately positive in one (titer 1 in
1000), and normal porphyrin levels in all.
Controlled pathomechanistic study
Repeated broadband UVA challenge induces abnormal
clinical reactions in severely PP but not in non-PP or healthy
controls. Age, sex, and clinical severity of psoriasis (PASI
score) were very similar between the groups (Table 1), and
similar antinuclear antibody positivity prevalence was noted
Table 1. Demographic and psoriasis severity data1 for participants at the time of study assessment
Photosensitive psoriasis (PP)
PP biopsy group
Healthy volunteer Non-photosensitive psoriasis Histology positive (PPpos) Histology negative (PPneg) All
No. of participants 11 9 4 6 20
Sex 8F, 3M 7F, 2M 4F 5F, 1M 19F, 1M
Age (years) 42 (24–58) 44 (31–58) 42 (19–62) 41 (20–65) 45 (19–74)
Age at onset of psoriasis (years) NA 25 (5–48) 12 (8–18) 11 (4–23) 11 (2–24)
PASI NA 4.6 (2.4–6.8) 4.3 (1.2–8.9) 5.5 (3.4–8.2) NA
Skin phototype I (number) 1 0 0 2 5
1Data are mean (range); NA, not applicable.
Figure 1. Clinical distribution of psoriasis in PP. (a) and (b) Photographs of a
patient with PP, demonstrating the involvement of photoexposed sites.
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in all groups. All 10 patients with PP developed visible
abnormal responses after bbUVA challenge to the forearm,
comprising macular erythema±scaling, but in comparison,
among the controls (n¼ 20), one healthy volunteer and one
non-PP patient showed only faint transient erythema after the
third bbUVA challenge.
Broadband UVA induces acanthosis, neutrophilic
infiltration, and specific changes in CD4þ , CD8þ ,
and CD45ROþ T lymphocytes in a proportion of patients
with PP. Histological features consistent with early psoriasis
were seen in 4 of 10 patients with PP (Figure 3). These
included acanthosis accompanied by an infiltrate of neu-
trophils and lymphocytes. No histological changes were
observed in other patients after bbUVA exposure. Histology-
positive PP (PPpos) patients were therefore assessed sepa-
rately from those with histology-negative PP (PPneg).
At 7 days after UV exposure, an overall between-subject-
group difference was seen in epidermal thickness (Po0.05). The
PPpos group showed a trend for epidermal thickening with time
after bbUVA exposure (P¼0.05, Supplementary Figure S1).
A significant increase in dermal neutrophilic infiltrate
developed in the PPpos group in comparison with the PPneg
group, the healthy skin group, and the non-PP group at
24 hours after bbUVA exposure, all Po0.05 (Figure 4).
The most notable changes in the T lymphocyte subsets
were observed 24 h after the final bbUVA provocation, with
significant between-group differences in CD4þ , CD8þ , and
CD45ROþ T cells, whereas no significant difference was
observed in natural killer cells (CD56). Marked early
(24 hours) increases in dermal CD4þ , CD8þ , and
CD45ROþ cells were observed in the PPpos group in
comparison with the control groups (Po0.05), whereas
CD8þ cells were significantly higher in the PPpos group
than the healthy group at baseline (Po0.05), and significantly
higher at 7 days in PPpos than in each of the other groups
(Po0.05, Figure 5).
DISCUSSION
We have phenotypically characterized a subset of severely
PP patients. The disorder, which we identified according to
the striking seasonal pattern of the psoriasis, that is, severe
during summer months and mild/absent during winter,
accompanied by a predominant involvement of sun-exposed
sites, shows behavior more analogous to a photosensitivity
disorder than to the more often witnessed, modestly
photoaggravated psoriasis. Accompanying this severely
photosensitive pattern of psoriasis, our patient group exhibits
the following key features: (i) a striking female predominance
(19 of 20) and a very young mean age of onset of psoriasis
(11 years), with a synchronous development of the photosensi-
tivity component in some patients (11 of 20); (ii) essentially
normal minimal erythema doses to UVB, UVA, and visible
light on monochromated light testing; and (iii) ease of
provocation of abnormal clinical responses to low-dose
bbUVA, with, in some instances, the rapid development of
psoriasiform features, contrasting with previous assumptions
with regard to the behavior of UV-sensitive psoriasis.
Previous studies of patients with psoriasis showing
sensitivity to sunlight were performed in less well-defined
Figure 2. Provocation response of PP to UVA exposure. UVA exposure
induces visible clinical change in PP, which can manifest as (a) macular
erythema, 24hours after final UVA exposure and (b) new scaly erythematous
lesions consistent with psoriasis, shown 1 week after final UVA exposure (arrows).
Figure 3. UVA-induced histological changes in PP. Photomicrographs of
hematoxylin-eosin-stained sections after UVA provocation at (a) baseline;
(b) 24 hours; (c) 7 days. Images (b) and (c) show UVA-induced histological
features consistent with early psoriasis, including epidermal thickening and
inflammatory cell infiltrate and (d) shows typical features of psoriasis,
including psoriasiform hyperplasia, parakeratosis, dermal papillary vessel
dilatation, and inflammatory cell infiltrate in a fully evolved psoriatic plaque
from the same patient. Scale bars¼ 100mm.
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patient groups and likely included several diagnostic entities
including psoriasis with a modest light aggravation, that is,
‘‘photoaggravated psoriasis’’. Nevertheless, a female pre-
ponderance (Lomholt, 1963; Bielicky and Kvicalova, 1964;
Ros and Eklund, 1987) and positive family history (Ros and
Eklund, 1987) have been reported, with early disease onset in
some (Bielicky and Kvicalova, 1964) but not all studies (Ros
and Eklund, 1987). Early reports regarding photoaggravated
psoriasis suggested that most were due to Ko¨bnerization in
fair-skinned patients, with reports of reduced erythemal
thresholds to UVB in some patients (Bielicky and Kvicalova,
1964; Frain-Bell, 1979; Ros and Wennersten, 1986). How-
ever, only 5 of 20 of our PP patients had skin phototype I, and
all had normal erythemal thresholds to UVB. We selected
low-dose bbUVA in preference to a UVB source for
provocation testing in this study to avoid confusion due to
the elicitation of psoriasis through Ko¨bnerization; future
studies might cautiously explore the impact of UVB
challenge. Ros and Wennersten (1986) reported coexistent
polymorphic light eruption in 18 of 35 patients with
photoaggravated psoriasis, and others reported photoaggra-
vated psoriasis in association with chronic actinic dermatitis
(Fujii et al., 2002; Sahoo and Kumar, 2002) and lupus
erythematosus (Millns and Muller, 1980; Doyle, 1984).
However, although features of polymorphic light eruption
were witnessed in three PP patients, we found no evidence of
any other coexisting photosensitivity disorder.
Our PP patients show some similarities with type 1
psoriasis, namely, early disease onset, positive family history,
and association with HLA–Cw6 (Henseler and Christophers,
1985). Notably, 490% of PP patients carried the HLA–
Cw*0602 allele, compared with B60% of patients with
early-onset psoriasis and 15% of healthy controls (Gudjons-
son et al., 2006); HLA–Cw6 is not associated with late-onset
psoriasis (Allen et al., 2005). Intriguingly, one study mentions
that HLA-Cw6-positive psoriasis patients are more likely to
report a beneficial effect of sunlight, but details of these
findings are lacking (Gudjonsson et al., 2002). The sex ratio
of our PP patients notably contrasts with non-photosensitive
early-onset psoriasis, in which the ratio is approximately
equal (Young et al 2004). The striking female predominance
in PP (95% of our group) is concordant with the observation
that the majority of patients diagnosed with photosensitivity
in photobiology units are female. Experimental data indicate
that estrogens can prevent UVB-induced immunosuppression
(Hiramoto et al 2004, Widyarini et al 2006) and that UVA
can reverse UVB-induced immunosuppression through estro-
gen receptors (Cho et al 2008). This requires a study in
humans, but it is conceivable that females are more resistant
to photoimmunosuppression and are thus more sensitive to
the photoactivating effects of UVA in certain photosensitivity
disorders, potentially including PP.
In our controlled study, prominent histological changes
were observed in biopsies from 4 of 10 PP patients, whereas a
clinical response was observed in all 10 PP patients. The
protocol used a low-dose, repeated UVA challenge to
investigate an early evolution of PP and avoided a higher
dose of UVA or UVB that might produce sunburn and
subsequent Ko¨bnerization; this approach is supported by
negative responses in our control groups. The P and PP
groups were very similar in characteristics, except for the
photosensitivity and the very young age of psoriasis onset in
PP (Table 1). We propose that the latter is an intrinsic feature
of PP and that the age of onset of the disorder is unlikely to
influence provocation outcome. The macular, sometimes
scaling, erythema we observed in PP thus seems to be a
pathological reaction to UVA, whereas the challenge may be
insufficient to fully provoke psoriasis. The histological
changes we observed, namely, acanthosis and neutrophilic
and lymphocytic infiltration, are typical early findings in
psoriasis. Acanthosis is believed to be secondary to immune
dysregulation, with stimulation by the Th17 cytokine IL-22,
which mediates the effects of IL-23 (Zheng et al., 2007; Ma
et al., 2008). A neutrophilic infiltration of epidermis and
dermis is observed in both early and established plaques of
psoriasis (van de Kerkhof, 2007). We found significant
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Figure 4. Dermal neutrophilic infiltration 24 hours after final UVA
provocation. Snap-frozen samples were cut in 10 mm sections, fixed in PFA,
and immunostained with a mouse anti-human neutrophil elastase primary
antibody. Dermal positively staining cells were manually counted on 9 high-
power ( 400 magnification) fields. (a) Healthy volunteer (N), (b) non-
photosensitive psoriasis (P), (c) histology-negative photosensitive psoriasis
(PPneg), (d) histology-positive photosensitive psoriasis (PPpos). Scale
bar¼ 100 mm. (e) Dermal neutrophilic infiltration was significantly higher in
the PPpos group in comparison with that in the PPneg group and in control
groups at 24 hours after bbUVA exposure. Data are median, interquartile
range, and range; *Po0.05.
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maximum of 24hours after the final UVA provocation. Plaques
of psoriasis are characterized by pathogenic T-cell subsets,
predominantly CD4þ cells in the dermis and CD8þ cells in
the epidermis (Bos et al., 1989; Bovenschen et al., 2005). The
majority of T lymphocytes in psoriasis are CD45ROþ memory
effector cells (Bos et al., 1989; Morganroth et al., 1991); these
may have a key pathomechanistic role (Griffiths, 2003;
Vissers et al 2004; van de Kerkhof, 2007). Our study supports
their early involvement in the evolution of PP.
In summary, we have characterized a group of patients
with psoriasis who show profound impact of season, striking
female preponderance, early onset of disease, and ease of
provocation of clinically abnormal changes after low-dose
UVA. The challenge was sufficient to provoke psoriatic
lesions in some individuals, demonstrating that psoriasis can
develop rapidly and directly after UV exposure. Histology
supports the diagnosis of psoriasis and indicates a role for
memory effector T cells in the early phase. This uncommon




Clinical/photobiological study. The participants (n¼ 20) were
patients with chronic plaque psoriasis attending the psoriasis clinic of
the Dermatology Centre, Salford Royal NHS Foundation Hospital,
Manchester, between November 2003 and April 2005, who were
identified to have severely PP as follows: a routine clinical questionnaire
of 340 psoriasis patients indicated 38 with a positive response to the
question ‘‘Is your psoriasis made worse by sunlight?’’ After an interview,
20 of the 38 patients were classified as having PP on the basis of a
history of psoriasis predominantly affecting sun-exposed sites, which
was severe in summer but minimal or absent in winter; thus, patients
with a milder element of photoaggravation were excluded.
Controlled pathomechanistic study. Ten of the PP patients who
participated in the above clinical study volunteered to participate in
the subsequent controlled investigative study. Nine non-photosensi-
tive chronic plaque psoriasis (P) patients were recruited from the
same psoriasis clinic as were the photosensitive patients after a
negative clinical questionnaire response regarding sunlight sensitiv-
ity. In addition, 11 healthy volunteers with normal skin (N) were
recruited after a poster advertisement.
The exclusion criteria for volunteers in both studies were
pregnancy, lactation, age o18 years and 475 years, and the use
of photosensitizing medication. Two patients were not included in
the analysis: one healthy volunteer who unexpectedly took medica-
tion with photosensitizing potential and who developed confluent
erythema after 3 consecutive days of UVA provocation, and one
patient with non-PP who developed an acute contact dermatitis
reaction to dressings. The study was approved by the Salford and
Trafford Research Ethics Committee and was conducted according to
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Figure 5. Dermal T-lymphocyte subset infiltration after UVA provocation, showing (a) CD4þ -, (b) CD8þ -, and (c) CD45ROþ -staining cells. For CD4 and
CD8 analysis, formalin-fixed and paraffin-embedded samples were sectioned 3–4 mm thick and immunostained using a standard method. Acetone-fixed 10 mm
sections were immunostained with primary antibody for CD45RO analysis. Positively staining dermal cells were manually counted on 9 high-power ( 400
magnification) fields. Dermal CD4þ and CD8þ counts were significantly higher in the PPpos group compared with those in the PPneg and N groups 24 hours
after UVA exposure, and CD8þ counts were significantly higher in PPpos than in all other groups at 1 week after UVA exposure. CD45ROþ counts were
significantly higher in PPpos than in healthy individuals at 24 hours after UVA exposure. Scale bar¼100 mm. Data are mean and SEM; *Po0.05, **Po0.01.
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Photobiological study of PP patients
A detailed photoinvestigation was performed in the Photobiology Unit
of the Dermatology Centre. Nineteen patients with PP underwent
monochromated light testing (High Intensity Monochromatic System,
L.O.T.- Oriel Ltd, Surrey, UK) on the skin of the mid-back with narrow
bandwidths of UVB, UVA, and visible radiation at 300, 320, 330, 350,
370, 400, 500, and 600nm (bandwidth 5nm at 300nm, 20nm at all
other wavelengths). Minimal erythemal doses were read at 24hours.
All 20 PP patients received bbUVA provocation testing (TL09, Philips
Lighting UK, Guildford, UK, 313–370nm), with exposure of a 5 cm2
area of ventral forearm skin to 20 J cm2 UVA over 1–3 consecutive
days. The site was examined at 24hours after each challenge. This low
dose was chosen to avoid the possibility of Ko¨bnerization and the
challenges were discontinued once an eruption was provoked. Blood
samples were taken for antinuclear antibody and extractable nuclear
antigens, and blood and urine samples were taken for porphyria
screening. HLA testing was carried out on 17 PP patients for
associations relevant to psoriasis (Cw6) and photosensitivity (DR4
typing, including DRB1*0407).
Controlled pathomechanistic study
Ten of the PP patients from the photobiological study were further
involved in an investigative mechanistic study, together with 20
controls (9P, 11N). Control individuals were interviewed to ensure
that they had no history of photosensitivity. Blood samples were
taken for antinuclear antibody and extractable nuclear antigens. All
volunteers received bbUVA provocation to their ventral forearm skin
on 3 consecutive days, as described for the photobiological study.
A series of four punch skin biopsies were taken from the bbUVA-
exposed forearm skin at (i) baseline (clinically normal skin before
provocation); (ii) 6 hours after the first UVA provocation; and
(iii) 24 hours and (iv) 1 week after the final UVA provocation. The
biopsies were bisected and half formalin fixed and half snap-frozen
in an optimal cutting temperature medium (Tissue-Tek; Miles, IN)
before storage at 80 1C.
Histology and immunohistochemistry
The samples underwent hematoxylin and eosin staining and
microscopic assessment by a dermatopathologist (TB) blinded to
the study. Epidermal thickness was measured microscopically by
image analysis (Leica Qwin; Leica Microsystems GmbH, Wetzlar,
Germany), with 10 measurements taken on each section. For CD4
and CD8 analysis, formalin-fixed and paraffin-embedded samples
were sectioned 3–4mm thick and dried at 58 1C overnight onto
adhesive-coated slides. The sections were immunostained using a
standard method. Antigen retrieval was carried out using a
microwave in 0.01M Tris-EDTA at pH 8.5. A primary antibody was
applied to the slides: CD4 (clone 1F6; Novocastra, Newcastle upon
Tyne, UK), dilution 1 in 50, and CD8 (clone C8/144B; Dako SA,
Glostrup, Denmark), dilution 1 in 25, each for 30minutes at room
temperature. Detection and visualization was by using the polymer-
peroxidase-DAB method (REAL EnVision, Dako UK Ltd, Ely, UK),
used according to the manufacturer’s recommendations, on a Dako
autostainer. Nuclei were stained with Harris’ hematoxylin.
Other immunohistochemical analyses were conducted on frozen
sections. Sections (10 mm) were fixed in chilled acetone (CD45RO)
or 4% paraformaldehyde (CD56, neutrophil elastase). In brief, the
sections were washed in tris-buffered saline before solubilization
(0.1% (v/v) Triton-X in tris-buffered saline) and treated with 0.6% (v/v)
hydrogen peroxide in methanol (30minutes) to block endogenous
peroxidase activity. Nonspecific binding was minimized by incuba-
tion with bovine serum albumin/normal serum (1–3% in tris-buffered
saline; 60minutes, room temperature), followed by overnight
incubation at 41C with a primary antibody (CD45RO, clone UCHL1,
Dako SA; CD56, clone M7304, Dako SA; neutrophil elastase,
MAB1056, Chemicon, Chandlers Ford, UK). Staining was visualized
using a standard peroxidase methodology (Vector ABC Elite, Vector
Laboratories, Peterborough, UK), using Vector SG as chromogen.
The sections were counterstained with nuclear fast red (Vector),
washed, dehydrated, and mounted with DePex (BDH, VWR
International, Lutterworth, UK). The stained sections were blinded
and randomized before manual counts of positive cells (9 hpf,  400
magnification, per volunteer per time point).
Statistical methods
Data are reported as mean (±SEM). Overall between-group
differences were tested using analysis of variance, and the post
hoc Tukey method or the two-sample t-test was used to assess
statistical significance between two groups. Fisher’s exact test was
used to test categorical variables. Po0.05 was considered to be
statistically significant. SPSS version 15.0 (SPSS Inc., Chicago, IL)
was used for the analysis.
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